Literature DB >> 14578885

Interaction of reelin signaling and Lis1 in brain development.

Amir H Assadi1, Guangcheng Zhang, Uwe Beffert, Robert S McNeil, Amy L Renfro, Sanyong Niu, Carlo C Quattrocchi, Barbara A Antalffy, Michael Sheldon, Dawna D Armstrong, Anthony Wynshaw-Boris, Joachim Herz, Gabriella D'Arcangelo, Gary D Clark.   

Abstract

Loss-of-function mutations in RELN (encoding reelin) or PAFAH1B1 (encoding LIS1) cause lissencephaly, a human neuronal migration disorder. In the mouse, homozygous mutations in Reln result in the reeler phenotype, characterized by ataxia and disrupted cortical layers. Pafah1b1(+/-) mice have hippocampal layering defects, whereas homozygous mutants are embryonic lethal. Reln encodes an extracellular protein that regulates layer formation by interacting with VLDLR and ApoER2 (Lrp8) receptors, thereby phosphorylating the Dab1 signaling molecule. Lis1 associates with microtubules and modulates neuronal migration. We investigated interactions between the reelin signaling pathway and Lis1 in brain development. Compound mutant mice with disruptions in the Reln pathway and heterozygous Pafah1b1 mutations had a higher incidence of hydrocephalus and enhanced cortical and hippocampal layering defects. Dab1 and Lis1 bound in a reelin-induced phosphorylation-dependent manner. These data indicate genetic and biochemical interaction between the reelin signaling pathway and Lis1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578885     DOI: 10.1038/ng1257

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  76 in total

1.  Lis1 reduction causes tangential migratory errors in mouse spinal cord.

Authors:  Katherine D Moore; Renee Chen; Marianne Cilluffo; Jeffrey A Golden; Patricia E Phelps
Journal:  J Comp Neurol       Date:  2012-04-15       Impact factor: 3.215

2.  Focusing forward genetics: a tripartite ENU screen for neurodevelopmental mutations in the mouse.

Authors:  R W Stottmann; J L Moran; A Turbe-Doan; E Driver; M Kelley; D R Beier
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

Review 3.  Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status.

Authors:  Naoya Yamashita; Yoshio Goshima
Journal:  Mol Neurobiol       Date:  2012-02-18       Impact factor: 5.590

4.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 5.  Extracellular matrix: functions in the nervous system.

Authors:  Claudia S Barros; Santos J Franco; Ulrich Müller
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

Review 6.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

7.  Reconstitution of the Reelin signaling pathway in fibroblasts demonstrates that Dab1 phosphorylation is independent of receptor localization in lipid rafts.

Authors:  Harald Mayer; Sarah Duit; Christoph Hauser; Wolfgang J Schneider; Johannes Nimpf
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

8.  Duplication of the Miller-Dieker Critical Region in a Patient with a Subtelomeric Unbalanced Translocation t(10;17)(p15.3;p13.3).

Authors:  R Ruiz Esparza-Garrido; A C Velázquez-Wong; M A Araujo-Solís; J C Huicochea-Montiel; M Á Velázquez-Flores; F Salamanca-Gómez; D J Arenas-Aranda
Journal:  Mol Syndromol       Date:  2012-07-10

9.  Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway.

Authors:  Tae-Ju Park; Tom Curran
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

Review 10.  Cytoskeleton in action: lissencephaly, a neuronal migration disorder.

Authors:  Hyang Mi Moon; Anthony Wynshaw-Boris
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2013 Mar-Apr       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.